BUSINESS PRACTICE
Digitalization Now
03/25/2020 | Stephanie Sutton
Digital technologies are here – but are they being used adequately?
BUSINESS PRACTICE
One Vision, One Culture, One Team
03/26/2020 | Rich Whitworth
Sitting Down With… Mike McMullen, President and CEO, Agilent Technologies, Santa Clara, California, USA.
VACCINES
What Lessons Have We Learned from Ebola?
03/24/2020 | Stephanie Sutton
How can we ensure we are better prepared to develop new vaccines and treatments for future infectious disease outbreaks?
BUSINESS PRACTICE
Accepting Responsibility for Global Health
03/23/2020 | Stephanie Sutton
We speak with Nik Kotecha, CEO of Morningside, to discuss why pharma companies have a responsibility to take the lead in helping others.
 
White Papers
Reduce downstream processing costs for mAbs with Tosoh’s 2-step platform

With this mAb purification process, combining a Protein A capturing and a polishing step on a salt-tolerant anion exchange resin, dsp costs can be reduced by 45% and production output increased by 58%. Read More.​​​​​​​

Protein stability analysis technologies for the biopharmaceutical industry

This buyer's guide discusses the available instrumentation for protein stability characterization, and what to consider when choosing stability assays. Protein stability and higher order structure is used to assist with biocomparability studies. Read More.

Generic Nasal Spray Design

How spray formulations and devices interact to impact drug delivery performance. Read More.

 
Product Profile
Oral Dose Design and Development

Catalent’s Better Treatments by Design™ service offers partners access to solutions and technology throughout the drug development process to achieve successful, patient-centric oral dose forms. Read More. 

 
Special Promotions
An Intensified Future

What do intensified and continuous bioprocesses have to offer? Miriam Monge from Sartorius outlines why these bioprocesses are beneficial for the pharmaceutical industry. Read More.

New Paradigms in Viral Safety

Biopharma manufacturers have been using the same approach to viral safety testing for decades. To meet the needs of next generation bioprocessing, the approach needs to evolve. Read More.

New launch: The Cell + Gene Curator

Subscribe now to receive this newly launched weekly newsletter – delivering the latest discoveries, process innovations, and business updates in the cell and gene therapy sector in a 5-minute read. Sign me up now.

 
Events

Be it a large congress at a huge venue or an expert meeting that fits around a table, these events are a fantastic way to network and educate yourself on the latest developments in the industry – so why not take a look at our list of upcoming events?

More Information